Northland Capital Markets Initiates Coverage On Cardlytics with Outperform Rating, Announces Price Target of $14
Portfolio Pulse from Benzinga Newsdesk
Northland Capital Markets has initiated coverage on Cardlytics (NASDAQ:CDLX) with an Outperform rating and a price target of $14.
June 18, 2024 | 12:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Northland Capital Markets has initiated coverage on Cardlytics with an Outperform rating and a price target of $14.
The initiation of coverage with an Outperform rating and a specific price target of $14 by Northland Capital Markets is likely to positively impact Cardlytics' stock price in the short term. Analyst ratings and price targets are significant indicators for investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100